Proteins in the insulin-secreting cell line MIN6 bind the imidazoline compound BL11282

FEBS Lett. 2008 May 14;582(11):1613-7. doi: 10.1016/j.febslet.2008.04.007. Epub 2008 Apr 15.

Abstract

The imidazoline BL11282 stimulates insulin release and alters islet proteomes. Subcellular fractions of MIN6 cells showed that the membrane fraction exhibited binding to BL11282 on a Biacore chip and to BL11282-labelled magnetic beads. Bound material extracted from the beads showed a approximately 50 kDa differential band upon SDS-PAGE and a weaker 100 kDa band. The former was sensitive to competitive removal by preincubation of the fraction with BL11282, then highlighting the approximately 100 kDa band. Masspectrometric analysis revealed the approximately 50 kDa band to be EF1A and the approximately 100 kDa band to be glucose regulated P94, both of interest in insulin synthesis and secretion.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amino Acid Sequence
  • Animals
  • Cell Fractionation
  • Cell Line
  • Chromatography, Liquid
  • Electrophoresis, Polyacrylamide Gel
  • Hypoglycemic Agents / metabolism*
  • Hypoglycemic Agents / pharmacology
  • Imidazoles / chemistry
  • Imidazoles / metabolism*
  • Imidazoles / pharmacology
  • Insulin-Secreting Cells / drug effects
  • Insulin-Secreting Cells / metabolism*
  • Mass Spectrometry
  • Mice
  • Molecular Sequence Data
  • Peptide Elongation Factor 1 / analysis
  • Peptide Elongation Factor 1 / metabolism*
  • Protein Binding
  • Surface Plasmon Resonance

Substances

  • BL 11282
  • Hypoglycemic Agents
  • Imidazoles
  • Peptide Elongation Factor 1